36716-73-1

Basic information

• Product Name: 3-Cyclohexen-1-one, 4-(4-fluorophenyl)-
• Synonyms: 1-(4-fluorophenyl)-cyclohexen-4-one;4-(p-Fluorphenyl)-3-cyclohexen-1-on
• CAS NO: 36716-73-1
• Molecular Formula: C12H11FO
• Molecular Weight: 190.217
• Mol File: 36716-73-1.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 3-Cyclohexen-1-one, 4-(4-fluorophenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Cyclohexen-1-one, 4-(4-fluorophenyl)-(36716-73-1)
• EPA Substance Registry System: 3-Cyclohexen-1-one, 4-(4-fluorophenyl)-(36716-73-1)

Safety Data

• Hazardous Substances Data: 36716-73-1(Hazardous Substances Data)

Upstream product

• 36716-69-5 4-(4-fluorophenyl)-4-hydroxycyclohexanone 
• 122770-39-2 4-(4-fluorophenyl)-4-hydroxy-cyclohexanone ethylene ketal 
• 4746-97-8 cyclohexanedione monoethylene ketal 
• 352-13-6 4-flourophenylmagnesium bromide 
• 13482-22-9 4-hydroxycyclohexanone 
• 40503-09-1 trans 1-(p-fluorophenyl)-1,4-cyclohexanediol 
• 460-00-4 1-Bromo-4-fluorobenzene 
• 122770-40-5 8-(4-Fluorophenyl)-1,4-dioxaspiro[4.5]dec-7-ene 
• 352-34-1 4-fluoro-1-iodobenzene 
• 680596-79-6 4,4,5,5-tetramethyl-2-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)-1,3,2-dioxaborolane 

Downstream Products

• 36716-76-4 4-(p-fluorophenyl)-3-cyclohexen-1-ol 
• 77412-73-8 4-(4-fluorophenyl)cyclohexanol 
• 36771-67-2 trans 4-(p-fluorophenyl)cyclohexanol methanesulfonate 
• 36826-95-6 cis 4-(p-fluorophenyl)cyclohexanol methanesulfonate 

Relevant articles and documents

Desymmetrizing Isomerization of Alkene via Thiazolinyl Iminoquinoline Cobalt Catalysis

We report a cobalt-catalyzed desymmetrizing isomerization of exo-cyclic alkenes to generate chiral 1-methylcyclohexene derivatives with good yields and enantioselectivities. A novel chiral thiazolinyl iminoquinoline ligand and its cobalt complex were desi

NOVEL 5 or 8-SUBSTITUTED IMIDAZO [1, 5-a] PYRIDINES AS SELECTIVE INHIBITORS OF INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES

Disclosed herein are 5 or 8-substituted imidazo [1, 5-a] pyridines and pharmaceutical compositions comprising at least one such 5 or 8-substituted imidazo [1, 5-a] pyridines, processes for the preparation thereof, and the use thereof in therapy. Disclosed herein are certain 5 or 8-substituted imidazo [1, 5-a] pyridines that can be useful for inhibiting indoleamine 2, 3-dioxygenase and/or tryptophane 2, 3-dioxygenase and for treating diseases or disorders mediated thereby.

Cyclohexylamine derivatives as subtype selective N-methyl-D-aspartate antagonists

Described are cyclohexylamine derivatives of Formula I Formula VI andFormula VIa and pharmaceutically acceptable salts thereof, wherein R1, g, *, R, V, B, E, Y, G, H, X1, and d are as defined in the description. The compounds of Formulas I and VI are antagonists of NMDA receptor channel complexes useful for treating cerebral vascular disorders such as, for example, stroke, cerebral ischemia, trauma, hypoglycemia, anxiety, migraine headache, convulsions, Parkinson's disease, aminoglycoside antibiotics-induced hearing loss, psychosis, glaucoma, CMV retinitis, opioid tolerance or withdrawal, chronic pain, or urinary incontinence.